Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Cardiovascular disease is the leading cause of morbidity and mortality worldwide. Cardio-protective drugs such as statins, antihypertensives and antithrombotic medications have been shown to be effective at preventing cardiovascular disease in older high-risk patients. However, each drug has both benefits and harms and there is debate on the extent to which such treatment should be administered to frail, multi-morbid patients. As such, clinical guidelines recommend using judgement when prescribing in frail older patients, emphasising a personalised approach to care which might include attempts to improve quality of life through deprescribing.

These guidelines are largely based on expert opinion and are vague on how to execute deprescribing due to a lack of evidence. Indeed, studies of current deprescribing practices are limited to small surveys and qualitative interview studies, and trials examining the impact of deprescribing are typically small with short periods of follow-up. Candidates are invited to join the Stratified Treatments Research Group to undertake a DPhil aiming to better inform deprescribing practice in routine primary care. This work will examine the extent to which cardio-protective medication deprescribing occurs in routine clinical practice, and develop a better evidence base for deprescribing interventions which can inform future randomised controlled trials and clinical guidelines for the care of older adults.

Potential research questions

  1. What is the prevalence of cardio-protective medication deprescribing in UK clinical practice?
  2. What evidence exists for the benefits and harms of cardio-protective medication deprescribing?
  3. What long term benefits and harms of cardio-protective medication deprescribing can be observed in routine electronic health record data?

Methods will include systematic reviews and causal inference epidemiology using routine electronic health records from large databases such as the CPRD or QResearch. Previous experience using such large databases is recommended.

This studentship is funded and linked to the supervisor's Wellcome-funded fellowship.



A funded studentship (funded at the home/EU fees rate) linked to the supervisor's Wellcome-funded fellowship is available for this project